Corrigendum

YH/SE/57/2026-27 October 06, 2026 The Listing Department Dept. of Listing Operations National Stock Exchange of India Limited BSE Limited, Exchange Plaza, 5th Floor, Plot No. C/1 Phiroze Jeejeebhoy Towers, G Block, Bandra-Kurla Complex, Bandra (E) Dalal Street, Mumbai – 400 051, India Mumbai - 400001, India Symbol: YATHARTH Scrip Code: 543950 ISIN: INE0JO301016 ISIN: INE0JO301016 Sub.: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (“SEBI Listing Regulations”) regarding Corrigendum to the Notice of Extraordinary General Meeting of the Company dated September 22, 2026 Ref.: Intimation under Reg. 30 of SEBI Listing Regulations bearing reference YH/SE/51/2026-27 Dear Madam/Sir, We refer to our above intimation, wherein the Company had informed about issuance of Notice of the Extraordinary General Meeting (“EGM”) of the Company scheduled to be held on Thursday, October 15, 2026 at 11:00 A.M. IST through Video Conferencing / Other Audio-Visual Means (“EGM Notice”). Subsequent to the issuance of the EGM Notice and pursuant to the applications filed by the Company for obtaining in-principle approval of BSE Limited and the National Stock Exchange of India Limited (“NSE”) with respect to Item No. 2 of the EGM Notice (i.e. issue of equity shares and warrants by way of a preferential issue on a private placement basis) (“Preferential Issue”), NSE has sought the Company to provide certain clarifications/ information in respect of the Preferential Issue, by way of issuing a corrigendum to the EGM Notice. Accordingly, the attached Corrigendum is being issued in continuation of the said EGM Notice, which shall form an integral part of, and shall always be read in conjunction with, the EGM Notice together with the Explanatory Statement annexed thereto (“Corrigendum”). This Corrigendum is being sent through electronic mode to those Members whose email addresses are registered with the Company/Registrar and Transfer Agent/ Depositories. This Corrigendum is also available on the website of the Company at https://www.yatharthhospitals.com/uploads/investors/corrigendum-egm-notice.pdf Please take the above information on record. Yours Faithfully, For Yatharth Hospital & Trauma Care Services Limited Ritesh Mishra Company Secretary & Compliance Officer M. No. A51166 Encl: A/a CORRIGENDUM TO THE NOTICE OF EXTRAORDINARY GENERAL MEETING Corrigendum to the notice of the Extraordinary General Meeting (“EGM”) of the Company to be held on Thursday, October 15, 2026 at 11:00 a.m. IST through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”) Yatharth Hospitals & Trauma Care Services Limited (“Company”) had issued a notice dated September 22, 2026 (“Notice”) for convening an EGM, scheduled to be held on Thursday, October 15, 2026 at 11:00 a.m. IST, through VC / OAVM. The Notice was dispatched to the Members of the Company on September 22, 2026 in compliance with the provisions of the Companies Act, 2013, read with the relevant rules made thereunder and the circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. Pursuant to the requirements of Regulation 28(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, the Company had filed applications for obtaining the in-principle approval of BSE Limited and the National Stock Exchange of India Limited (“NSE”) for the proposed preferential issue of equity shares and warrants as detailed in Item No. 2 of the Notice together with the explanatory statement annexed thereto. NSE vide its communication dated September 28, 2026, has asked the Company to provide certain clarifications and additional information with respect to the tenure of warrants, objects of the proposed preferential issue, use of the proceeds and the valuation mechanism for a preferential issue under the articles of association of the Company. NSE has also suggested to issue corrigendum to the Notice clarifying the same. Accordingly, in continuation to the Notice together with the explanatory statement annexed thereto this corrigendum (“Corrigendum”) is being issued and same shall be deemed to be an integral part of and should be read in conjunction with the Notice. Pursuant to this Corrigendum, Members are hereby informed and requested to take note of the following changes in the explanatory statement to Item No. 2 as set out in the Notice: Following Paragraphs of the Explanatory Statement to the EGM Notice dated September 22, 2026 stand replaced as under (with the relevant change italicized for reference): A. Paragraph 2 of the table, on page 17 of the Notice shall stand replaced as under: 2. Kinds of securities (i) Up to 1,30,26,516 (One Crore Thirty Lakhs Twenty Six Thousand offered and the Five Hundred Sixteen) fully paid-up equity shares of the price at which the Company of face value of INR 10 (Indian Rupees Ten) each (the security is being “Subscription Shares”), at an issue price of INR 985.17 (Indian offered Rupees Nine Hundred Eighty Five and Seventeen Paisa only) per Subscription Share, for an aggregate subscription share consideration of INR 12,83,33,32,767.72 (Indian Rupees One Thousand Two Hundred Eighty Three Crore Thirty Three Lakhs Thirty Two Thousand Seven Hundred Sixty Seven and Seventy Two Paisa Only). (ii) Up to 1,89,47,664 (One Crore Eighty Nine Lakhs Forty Seven Thousand Six Hundred Sixty Four) warrants of the Company (the “Subscription Warrants”), each carrying the right to subscribe to 1 (one) fully paid-up equity share of face value of INR 10 (Indian Rupees Ten) each of the Company, at a per Subscription Warrant price of INR 985.17 (Indian Rupees Nine Hundred Eighty Five and Seventeen Paisa), of which 25% is payable upfront and the balance 75% on exercise. The tenure of the Subscription Warrants shall not exceed 18 (eighteen) months from the date of their allotment, with 18 (eighteen) months being the maximum permissible tenure in compliance with Regulation 162(1) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 (“SEBI ICDR Regulations”). Accordingly, the Subscription Warrants may be exercised any time prior to the 18 (eighteen) months. Further, in the event the proceeds from the issuance of Subscription Warrants is fully utilized by the Company towards the stated objects within 6 months from receipt of the proceeds, the Proposed Allottee may exercise the Subscription Warrants within 15 months from the date of allotment to ensure that the Company can utilize such proceeds towards the objects. The 15-month period does not constitute a separate or alternative tenure for the Subscription Warrants, and is intended only to indicate the period within which the Company expects the Proposed Allottee to exercise the Subscription Warrants, based on the estimated schedule for deployment of funds towards the objects of the proposed preferential issue. B. Paragraph titled Objects of the Preferential Issue and Use of Proceeds, on page 13 of the Notice shall stand replaced as under: 1. The proceeds from the proposed Preferential Issue are proposed to be utilised for the expansion and development of the Company’s hospital network and infrastructure or expenditure requirements of the Company and its subsidiaries (including, by way of investment in its subsidiaries) and other general corporate purposes. Given that the funds to be received against the Subscription Warrant conversion will be in tranches and the quantum of funds required on different dates may vary, therefore, the broad range of intended use of the funds for the above objects is set out hereinbelow: Nature of utilization Amount (in INR) Tentative timeline for utilization Expansion and development of 13,12,50,00,227.58 3 years from the date of the Company’s hospital network allotment of Subscription and infrastructure or Shares and Subscription expenditur [Showing first 8,000 characters — download PDF for full document]